The recognition and repair of DNA double-strand breaks (DSBs) is a complex process that draws upon a multitude of proteins. This is not surprising since this is a lethal lesion if left unrepaired and also contributes to genome instability and the consequential risk of cancer and other pathologies. Some of the key proteins that recognize these breaks in DNA are mutated in distinct genetic disorders that predispose to agent sensitivity, genome instability, cancer predisposition and/or neurodegeneration. These include members of the Mre11 complex (Mre11/Rad50/ Nbs1) and ataxia-telangiectasia (A-T) mutated (ATM), mutated in the human genetic disorder A-T. The mre11 (MRN) complex appears to be the major sensor of the breaks and subsequently recruits ATM where it is activated to phosphorylate in turn members of that complex and a variety of other proteins involved in cellcycle control and DNA repair. The MRN complex is also upstream of ATM and ATR (A-T-mutated and rad3-related) protein in responding to agents that block DNA replication. To date, more than 30 ATM-dependent substrates have been identified in multiple pathways that maintain genome stability and reduce the risk of disease. We focus here on the relationship between ATM and the MRN complex in recognizing and responding to DNA DSBs.
Introduction
Exposure of cells to ionizing radiation and radiomimetic chemicals gives rise to a variety of DNA damage, including double-strand breaks (DSB) (Ward, 1985) . DNA damage during S phase can lead to the collapse of DNA replication forks also generating DNA DSB (Paulsen and Cimprich, 2007) . DSBs also arise under normal conditions during rearrangement of immunoglobulin and T-cell receptor genes (Livak, 2004; Dudley et al., 2005) .
Induced DNA DSBs are potentially lethal to the cell and therefore must be rapidly recognized and repaired to avoid genetic damage (Agarwal et al., 2006) . Not unexpectedly there are cellular mechanisms in place to recognize and signal the presence of DNA DSB to the cell-cycle checkpoints to delay the passage of cells through the cycle and facilitate DNA repair (Zhou and Elledge, 2000) . Signalling also occurs to the DNA repair machinery. Two major mechanisms exist for the repair of the DNA DSB, homologous recombination repair and non-homologous end joining (NHEJ) (Valerie and Povirk, 2003) . Ultimately, it is paramount that the break be repaired by one of these mechanisms, but this is preceded by detection, recognition and signalling of the break to other cellular processes such as cell-cycle control and transcriptional events (Zhou and Elledge, 2000) . Most progress on the recognition and signalling of DNA DSB has been acquired from a series of rare human genetic disorders sharing sensitivity to agents that cause breaks in DNA . Prominent among these are ataxia-telangiectasia (A-T) with A-T-mutated (ATM) being the mutated protein; Nijmegen breakage syndrome (NBS), Nbs1 defective; A-T like syndrome (A-TLD), Mre11 defective; and A-T and Rad3 related (ATR) (Seckels), ATR defective. (Table 1) . A single case with a defect in Rad50 protein has also been described (Dork et al., in preparation) . It should be pointed out that while the gene products in all of these syndromes recognize and signal DNA DSB, they do not show dramatic reductions in capacity to repair these breaks (Foray et al., 1997; Girard et al., 2000; Riballo et al., 2004) . On the other hand, defects in DNA-PKcs, Ku70/80 and ligase IV, all of which participate in NHEJ, are associated with more marked defects in the capacity to repair DNA DSB (Featherstone and Jackson, 1999; Meek et al., 2004; Orii et al., 2006) . In this review, the emphasis will be on the mre11 (MRN) complex and ATM. As we shall see the MRN complex is the primary sensor of DNA DSB. It recruits ATM to the break where it is activated and subsequently phosphorylates members of the complex and a variety of other proteins that signal to different cellular processes. This ensures that DNA repair complexes efficiently remove and repair the break. Failure to do so results in genome instability, which may give rise to cancer, neurodegeneration and other pathologies.
The MRN complex acts as a sensor of DNA DSB
The MRN complex is a highly conserved protein complex involved in the following DNA repair mechanisms: both homologous recombination repair and NHEJ, DNA replication, telomere maintenance and in signalling to the cell-cycle checkpoints (D'Amours and Jackson, 2002; van den Bosch et al., 2003) . The complex is rapidly localized to nuclear foci in response to radiation exposure (Maser et al., 1997) , which were shown to be sites of DNA damage using irradiation masks and ultrasoft X-rays (Nelms et al., 1998) . It was subsequently shown that ATM, which phosphorylates Nbs1 for activation of the S-phase checkpoint, was not required for association of the MRN complex with sites of DNA damage (Mirzoeva and Petrini, 2001 ). However, the complex also binds tightly to chromatin in the absence of DNA damage during S phase (Mirzoeva and Petrini, 2003) . The Mre11/ Rad50 complex binds to DNA as a heterotetramer, tethering broken ends of a DSB (de Jager et al., 2001) . The binding appears to be achieved through the two DNA-binding motifs of Mre11 (van den Bosch et al., 2003) . This is arranged as a globular domain with Rad50 Walker A and B motifs (ATPase domains) and the bridging of DNA molecules is achieved through CXXC sequences in the middle of Rad50 (Figure 1 ). These sequences are displayed at the ends of coiled-coil regions and appear to dimerize by the coordination of a Zn 2 þ ion (Hopfner et al., 2002) . Upon binding to DNA, the dynamic architecture of the MRN complex is altered to give rise to parallel orientation of the coiled-coils of Rad50, preventing intracomplex interaction and favouring intercomplex association (Moreno-Herrero et al., 2005) . Association with Rad50 stimulates both the exonuclease and endonuclease activities of Mre11 (Paull and Gellert, 1998; Trujillo and Sung, 2001) and Nbs1 stimulates its endonuclease activity (Paull and Gellert, 1999) . The complete complex can also partly unwind or dissociate a short DNA duplex with a 3 0 overhang and this activity is stimulated by ATP (Paull and Gellert, 1999) . It seems likely that these and other activities may be responsible for the processing of DNA DSB prior to repair. However, it is evident that other nucleases, such as Artemis, also play a role in DSB processing at least in a subgroup of breaks with damaged termini (Riballo et al., 2004) . Thus, the initial event in recognizing and responding to DNA DSB is the binding of the Mre11 complex, which tethers the broken ends together as a means of preparing for repair.
ATM is recruited to and activated by the MRN complex
Evidence using rare genetic disorders and mouse models While the recruitment of the MRN complex to damaged DNA is rapid, so too is the activation of ATM (Bakkenist and Kastan, 2003; Kozlov et al., 2003) , making it difficult to discern the sequence of events involved. If the MRN complex were the sensor of DNA breaks then it might be expected that it would be upstream of ATM activation. Evidence for this was provided from studies with NBS and A-TLD cells, hypomorphic for members of the complex; in cells in which the MRN complex was depleted during viral infection; in vitro investigations using recombinant proteins and in Xenopus extracts reconstituted for DNA damage signalling. In these experiments, ATM activation was determined by autophosphorylation on S1981 or indirectly through its capacity to phosphorylate downstream substrates. ATM activation was retarded in NBS cells in response to neocarzinostatin treatment (Uziel et al., 2003) . The extent of reduction in activity was comparable in a moderate A-TLD patient, compound heterozygous for nonsense and missense mutations in Mre11, and was severely affected in a patient homozygous for a nonsense Mre11 mutation that markedly reduced the level of truncated Mre11 protein. Cerosaletti and Concannon (2004) showed that an Nbs1 construct (N6FR5), retaining the Mre11-binding site, gave rise to nuclear expression of Mre11/ Rad50 and stimulated ATM activation. This is also the case for the most common NBS mutation (657D5, 5 bp deletion giving rise to hypomorphic allele), which generates two fragments of the Nbs1 protein (Digweed et al., 1999) . The N-terminal fragment contains the Mre11 binding site while the C-terminal fragment contains a conserved domain responsible for recruitment of ATM (Falck et al., 2005) . Cerosaletti and Concannon (2004) showed that Mre11/Rad50 alone stimulated ATM activation after low doses of radiation. However, in these experiments, this complex was retained in the nucleus by an Nbs1 construct, NbFR5, that contained the N-terminal Mre11-binding site, but was lacking in the FHA and BRCT domains. The importance of the ATM-binding domain on Nbs1 was also confirmed when it was shown that NBS cells expressing NbFR5DAtm, lacking ATM binding site, had dramatically reduced levels of ATM activation (Cerosaletti et al., 2006) . Surprisingly, as with other facets of ATM activation, Nbs mouse mutants behaved differently. Difilippantonio et al. (2007) reconstituted Nbs1-knockout mice with human bacterial artificial chromosome transgenes carrying specifically engineered mutants in different Nbs1 domains to investigate ATM activation and signalling. Two of these mutants, Nbs1 657D5 corresponding to the most common mutation in NBS patients and Nbs1 tr735 lacking 20 amino acids at the C-terminus, showed normal levels of Atm activation as determined by S1987 (corresponding to human S1981) phosphorylation. Atm signalling was reduced somewhat in both mutants at low radiation (2 Gy) dose but was normal at a higher dose (8 Gy) and no defects were evident in cellcycle checkpoint activation. Co-immunoprecipitation of Atm with Nbs1 tr735 was observed and Atm was recruited to laser-induced sites of DNA damage in Nbs1 tr735 -transfected cells. However, it was demonstrated that the C-terminus of Nbs1 was required for efficient radiationinduced apoptosis. Thus, unlike the data for human cells, the C-terminus of Nbs1 in these specially engineered mice was dispensable for Atm recruitment and activation. Since conditional deletion of Nbs1 almost abolishes Atm activation (Difilippantonio et al., 2005) the authors suggest that the lack of requirement for the C-terminus can be explained by other interactions between Atm and members of the complex. As support for this they cite data from Lee and Paull (2004) that provide evidence for multiple independent contacts between ATM and the MRN complex. Another mouse model of Nbs1, prepared by the more conventional approach, lacking the C-terminal 24 amino acid (Nbs1
DC/DC
) shared some of the phenotype of NBS cells and that from Nbs1 tr735 (Stracker et al., 2007) . Nbs1 DC/DC cells showed normal Atm S1987, p53 and Chk2 phosphorylation, but were defective in structural maintenance of chromosomes (SMC1) and BH3 interacting domain death agonist (BID) phosphorylations. The latter was compatible with an attenuated apoptotic response in Nbs1 DC/DC and in agreement with the results of Difilippantonio et al. (2007) on the importance of the C-terminus of Nbs1 for apoptosis. However, as for NBS, Nbs1 DC/DC were defective in the intra-S-phase checkpoint. Overall, the data suggest that ATM recruitment is not mediated solely by the Nbs1 C-terminus. This is supported by the evidence that ATM makes multiple contacts with the MRN complex (Lee and Paull, 2004; Stracker et al., 2007) . What is evident from these studies is the difference in phenotype, which cannot be explained solely by the difference between human and mouse. The variability in the extent of the defect in the different systems might be explained by the cell type and/or compensatory mechanisms. Understanding in more detail how the MRN complex recruits and activates ATM will assist in resolving these apparent discrepancies between systems/ species.
Viral infection and in vitro models to investigate the role of MRN complex in ATM activation
Infection of cells with wild-type adenovirus gives rise to altered localization and proteosome degradation of members of the MRN complex (Stracker et al., 2002) . In E4 early gene region mutants of adenovirus, concatamerization is observed which requires functional Mre11 and Nbs1 and these proteins are localized to foci adjacent to viral replication centres. Carson et al. (2003) subsequently showed that this end-joining of viral genomes for E4-deleted adenovirus was accompanied by Nbs1 phosphorylation reminiscent of that seen in response to DNA damage (Gatei et al., 2000) . These results suggested that ATM was being activated as determined by ATM, pS1981 localization to E4-deleted viral centres (Carson et al., 2003) . Degradation of the MRN complex prevented this autophosphorylation of ATM. These results also show that the MRN complex operates upstream from ATM. E4-deleted adenovirus infection not only activated ATM but also ATR signalling, suggesting that the complex may also be upstream from ATR. Additional evidence in support of this was reported by Zhang et al. (2005) who showed that the MRN complex is required for ATR-dependent phosphorylation of SMC1; for cell survival; the intra-S-phase checkpoint and genomic stability after exposure to UV. Furthermore, recruitment of ATR to sites of radiation-induced DNA damage and activation requires ATM and components of the MRN complex (Adams et al., 2006; Myers and Cortez, 2006) .
The ability of the MRN complex to function as a DNA DSB sensor has also been demonstrated in vitro Paull, 2004, 2005) . They demonstrated direct activation of ATM by the MRN complex using Baculovirus expressed complex members in the presence of immunoprecipitated ATM. Under these conditions, ATM was shown to phosphorylate p53, Chk2 and H2AX; however, the importance of the integrity of the complex for this activation was evident from only partial stimulation of ATM kinase when Nbs1 was left out. Adding DNA to this mixture revealed MRN complex binding, unwinding of the free ends, recruitment of ATM and dissociation of the inactive dimer followed by substrate phosphorylation (Lee and Paull, 2005) . While Mre11/Rad50 could recruit ATM to DNA ends, it was incapable of stimulating ATM kinase activity. A phosphorylation site mutant of ATM (S1981A) was capable of forming dimers, dissociated into monomers in the presence of MRN complex and DNA, and was active with p53 and Chk2 substrates. This lack of requirement for autophosphorylation for activation in vitro was similar to that reported earlier by Bakkenist and Kastan (2003) . Indeed, there are several reports of ATM activation in vitro and in vivo without the requirement for S1981 autophosphorylation (Kozlov et al., 2003; Hamer et al., 2004; Powers et al., 2004) .
Xenopus cell-free extracts have been shown to recapitulate signalling pathways induced by DNA damage and have also contributed to delineation of the roles of Mre11 and ATM in this process (Costanzo et al., 2000 (Costanzo et al., , 2001 . Depletion of Mre11 from these extracts abrogated the response to DNA DSB. While full-length Mre11 restored this response, Mre11 lacking the C-terminal DNA-binding domain failed to do so. This group subsequently showed that fragmented DNA assembles with proteins into macromolecular structures enriched in the MRN complex and activated ATM (Costanzo et al., 2004) . Assembly of these structures was dependent on Mre11 but not on ATM and Mre11 was phosphorylated. This phosphorylation of Mre11 may play a role in processing of DNA ends, since this modification has been shown to correlate with increased nuclease activity (Costanzo et al., 2001) . In the absence of the MRN complex, some activation of ATM was observed and this was dependent on the concentration of DNA free ends (Dupre et al., 2006) . In this system, ATM activation as determined by monomerization, did not occur in MRN complex-depleted extracts. However, at higher concentrations of DNA ends the requirement for the MRN complex for ATM monomerization was bypassed. While the ATM monomer generated by only DNA ends was active and capable of phosphorylating H2AX, it was only weakly autophosphorylated on S1981. These data show that the dimer to monomer transition can occur without autophosphorylation unlike that reported for ATM activation in human cells (Bakkenist and Kastan, 2003) , but it should be kept in context since these experiments were performed in vitro. Dupre et al. (2006) showed that the DNA-tethering activity of the MRN complex promotes the formation of DNA damage signalling complexes, ATM monomerization and ATM activation. The overall model derived from this studies envisages a two-step mechanism, the first is an MRN complex-dependent DNA-tethering activity that increases the local concentration of DNA ends to trigger ATM monomerization followed by ATM activation and autophosphorylation. As pointed out above the sequence of events is different to that proposed for human cells where the monomerization occurs as a consequence of autophosphorylation and activation.
Focusing on the DNA DSB for ATM activation Exposure of cells to ionizing radiation gives rise to approximately one DNA DSB per 30 cGy. Since these are distributed in a largely random fashion across the genome, it is not possible to report the molecular events occurring at individual breaks. Chromatin immunoprecipitation followed by real-time PCR provides a sensitive measurement of the kinetics and spatial distribution of changes to chromatin and recruitment of DNA repair proteins in the proximity of the break site. Tsukuda et al. (2005) employed Saccharomyces cerevisiae with an inducible HO endonuclease to introduce a DSB at mating type (MAT) that is only receptive to repair by NHEJ. As observed previously (Schroff et al., 2004) g-H2A accumulated rapidly and extensively around the break but g-H2A levels were lower closer to the break. This was followed by loss of H2B and H3 histones, exposing DNA to nuclease susceptibility. Histone loss was dependent on the S. cerevisiae Mre11 complex, MRX (Mre11/Rad50/Xrs2) (Usui et al., 2006) and the ATP-dependent nucleosome remodelling complex INO80 (Shen et al., 2000) . Using an introduced IScel site or radiation doses generating 2 breaks per S. cerevisiae nucleus, Lisby et al. (2004) demonstrated that Mre11 is the first protein detected at the break and deletion of either Rad50 or Xrs2 interferes with the assembly of Mre11 foci. This complex was required for the recruitment of Tel1 kinase (homologue of ATM) and it was suggested that this interaction may play a determining role as to whether homologous recombination repair or NHEJ operates to repair the break (Lisby et al., 2004) . Recruitment of HR proteins Rad51 and Rad52 only occurs when Mre11 and Tel1 foci disassemble. IScel cleavage has also been utilized in human cells to demonstrate recruitment of Mre11 and other repair proteins to the cleavage site (Rodrigue et al., 2006) . To understand the roles of ATM and Nbs1 in chromatin structure modulation at a specific DNA DSB, Berkovich et al. (2007) used the eukaryotic homing endonuclease I-Ppol (15-bp recognition sequence) to cleave DNA at endogenous target sites in the human genome. Expression of this enzyme in human cells gives rise to approximately 30 DSB per cell. In this case, expression was targeted to the nucleus with 4-hydroxytamoxifin by fusing a mutant oestrogen receptor hormone-binding domain to I-Ppo1 in a retroviral vector. Addition of 4-hydroxytamoxifin to MCF7 cells, infected with this construct, caused cleavage of DNA, ATM activation and ATM-mediated downstream signalling. Under these conditions, dimeric ATM dissociated to the monomeric form, and this was dependent on ATM kinase activity and the S1981 autophosphorylation site.
The ATM kinase inhibitor KU55933 (Hickson et al., 2004) inhibited ATM activation and this protein was not detected at the site of cleavage, but as expected Nbs1 still localized to the break, since this is ATM-independent. Furthermore, while ectopically expressed ATM localized to I-Ppo1 DSB in A-T cells, neither a kinase dead nor an S1981A mutant form of ATM bound to the DSB. These data are at variance from those observed in vitro where unphosphorylated dimers bind to DNA to become activated (Lee and Paull, 2005) , and in Xenopus extracts where ATM monomerization is followed by ATM autophosphorylation and activation (Dupre et al., 2006) .
DNA damage response: ATM/MRN interdependence
As mentioned above, the MRN complex and ATM are interdependent for the recognition and signalling of DNA DSB. The complex binds to DNA DSB independent of ATM, recruits ATM to the break where it is activated and then acts as a substrate and adapter for ATM signalling (Figure 2 ). While the requirement of MRN for ATM activation is not absolute, it is evident that cells deficient in Nbs1 and Mre11 show some abnormalities. This can be explained by the observations that ATM is activated with reduced efficiency in the absence of DNA DSB (Bakkenist and Kastan, 2003; Difilippantonio et al., 2005) . The stimulus in these cases appears to be alteration in chromatin structure and it is possible that such alteration could contribute to ATM activity remote from a DSB. Exposure of cells to chromatin-modifying treatments activates ATM to phosphorylate p53 but not H2AX, SMC1 and Nbs1, supporting the importance of the break or rather its interaction with the MRN complex for the phosphorylation of substrates other than p53. This is further substantiated by the results with Nbs1-deficient cells, where ATM activation was reduced at low doses of radiation (0.3 Gy), but as the dose was increased there was no significant effect on ATM phosphorylation. However, phosphorylation of downstream substrates such as SMC1 was deficient even at higher doses. This can be explained by the observation that ATM pS1981 showed a diffuse pattern of nuclear staining in Nbs1-deficient cells, failing to form discrete foci as observed in control cells. While ATM is activated in Nbs1-deficient cells, its inability to be anchored to the MRN complex at sites of DNA damage interferes with normal signalling. This is compatible with the model for ATM activation outlined in Figure 2 . A clearer picture of the series of events involved has been provided by Berkovich et al. (2007) using I-Ppol cleavage at a specific site on chromosome 1. The dynamics of recruitment of different proteins to the break were initially investigated in G 1 phase-synchronized cells (repair by NHEJ). Chromatin immunoprecipitation analysis revealed a time-dependent accumulation of ATM at the break accompanied by loss of histone H2B from the break site, indicating nucleosome disruption to expose the damaged DNA. This was followed by the accumulation of the NHEJ protein XRCC4. In the absence of Nbs1, there was no recruitment of ATM or loss of H2B. Higher levels of persistent DNA DSB were evident in cells lacking functional ATM or Nbs1 pointing to a repair defect, which agrees with earlier reports of defective repair of DNA DSB in both A-T and NBS cells (Foray et al., 1997; Riballo et al., 2001) . While Nbs1 largely accumulated at the break, ATM was enriched not only at the break but also in the flanking regions on chromatin. On the other hand, gH2AX was not found at the DNA DSB but rather was enriched adjacent to the break.
The model by Berkovich et al. (2007) envisages an initial binding of the MRN complex to the DNA DSB followed by Nbs1-dependent association of ATM with the break and surrounding area. In parallel, chromatin is disrupted as evidenced by the loss of H2B. As ATM is displaced from the break site, XRCC4 is recruited presumably as part of a NHEJ mechanism to repair the DSB. However, displacement of ATM from the break site leads to its continued association with flanking regions of chromatin. What these data also show is that inactive or phosphorylation site mutants (S1981A) of ATM fail to bind to DNA DSB. This remains a point of contention since cells from a bacterial artificial chromosome reconstituted mouse mutant for this site (S1987A) showed rapid recruitment of wild type and S1987A ATM to sites of DNA DSB (Pellegrini et al., 2006) . Atm
TgS1987A Atm À/À B cells showed enhanced retention of Atm-S1987A protein on chromatin after DNA damage. Furthermore, irradiated cells showed normal phosphorylation of Chk2, SMC1 and p53 and they were not hypersensitive to radiation. As mentioned above, mutant ATM-S1981A was also shown to bind to DNA ends and can be activated in vitro (Lee and Paull, 2005) . Pellegrini et al. (2006) speculate that after Atm becomes activated at the DSB where it becomes accessible to rapid phosphorylation as a consequence of a high local concentration of Atm protein. In this case, autophosphorylation as well as Atm-dependent substrate phosphorylation are downstream from Atm activation. Thus, these data suggest that the mechanism of activation is considerably different in mouse and human and there are discrepancies between mice mutants.
Perspective
The response to DNA DSB represents a complex, highly branched signalling network controlled by the MRN complex and ATM (Shiloh, 2006 ). An extensive ATMregulated network has been established using showcase for ATM-related pathways (SHARP; http://www.cs. tan.ac.il/Bsharp). The substrates included play important roles in DNA repair, cell-cycle control and transcription to determine the fate of the cell. Thus, it is imperative that the initiating or upstream events, in this case ATM activation, are tightly controlled. As we have seen ATM is rapidly recruited to DNA DSB via the MRN complex. It seems likely that 'partial' activation of ATM occurs prior to localization to the break site and there is some evidence that this is achieved through local alterations in chromatin structure (Bakkenist and Kastan, 2003) . ATM thus activated has the capacity to phosphorylate the nucleoplasmic substrate p53, but not other substrates such as Chk2, SMC1 and BRCA1 which depend on MRN (Kitagawa et al., 2004) . This partially active form may represent ATM localized to regions adjacent to the break (Berkovich et al., 2007) . This is further supported by the observation that, in the absence of Exposure of cells to ionizing radiation introduces DSB into DNA. This leads to opening of chromatin and nucleosome disruption, which is dependent upon both ATM and MRN. The MRN complex a sensor of the DSB, localizes to the break to tether the ends and recruit ATM. This induces ATM autophosphorylation on at least three sites, which leads to dissociation of an inactive dimer to form active monomeric ATM. There is not an absolute requirement for MRN for this process and indeed there is some evidence that alteration to chromatin structure alone leads to partial activation of the ATM pool. Once activated by the MRN complex, ATM then phosphorylates members of this complex which act as adaptors for downstream signalling through ATM-dependent phosphorylation of other substrates. A list of some of the greater than 30 substrates is included. It should be pointed out that this is the model that applies to events in human cells. The mouse data are not the same for all steps. ATM, ataxia-telangiectasia mutated; DSB, doublestrand break.
Nbs1, active ATM is not present in foci but rather in a diffuse pattern in the nucleus and only p53 phosphorylation is observed at short times after irradiation. It is possible that H2AX may also be a substrate for ATM adjacent to the break and that enhancement of this response is due to further activation of ATM at the break site. It is difficult to test the former, since normal numbers of gH2AX foci are observed even in the absence of ATM (McManus and Hendzel, 2005) . In addition, while further activation involves MRN, it is also evident that MDC1 plays an important role in amplifying ATM-dependent DNA-damage signalling (Bekker-Jensen et al., 2006; Lou et al., 2006) . This may be a later event with MDC1, providing a platform to stabilize the complex and sustain ATM signalling. As discussed above, ATM autophosphorylation on S1981 appears to be a crucial event for recruitment and activation of ATM in human cells (Bakkenist and Kastan, 2003; Berkovich et al., 2007) . However, other post-translational changes to ATM are an inherent part of the activation process. Kozlov et al. (2006) used mass spectrometry to identify three phosphopeptides from ATM from radiation-exposed cells. Use of tandem mass spectrometry identified the specific phosphorylation sites as S367, S1893 and S1981. Phosphorylation site mutants (S367A, S1893A and S1981A) were defective in ATM signalling and failed to correct either radiosensitivity or the defective G 2 /M checkpoint in A-T cells. These data suggest that all three autophosphorylation sites are important for ATM activation and signalling. What is not clear yet is whether ATM pS367 and pS1893 coincide with pS1981 at the break site or whether they are associated with movement of ATM from the site to the flanking regions. Not surprisingly, protein phosphatases have also been shown to play a role in ATM activation (Ali et al., 2004; Goodarzi et al., 2004) . DNA-damaged-induced acetylation of ATM has been reported by Sun et al. (2005) and this was shown to run in parallel with pS1981 after radiation exposure. They identified the Tip60 histone acetyltransferase as the enzyme responsible and revealed that a dominant negative form of Tip60 reduced both acetylation and autophosphorylation of ATM. This enzyme was constitutively associated with ATM and its acetylase activity increased in response to DNA damage. No dependence for MRN was shown for Tip60 activation of ATM nor for downstream substrate phosphorylation of p53 or Chk2 (Jiang et al., 2006) . This is somewhat at variance with other results where MRN-independent activation of ATM only resulted in p53 phosphorylation (Kitagawa et al., 2004) .
These data reveal that ATM activation is indeed controlled by a complex series of events in human cells. These steps are depicted in Figure 2 . An important aspect of this model is the interdependence of ATM and the MRN complex. Since hypomorphic mutations in Nbs1 and Mre11 do not dramatically affect the ability of the complex to localize to DNA DSB and recruit and activate ATM, it is possible to define the role of phosphorylation changes in members of the complex for downstream signalling. ATM is recruited to the complex present at the DNA DSB for 'full activation'. Once activated it then phosphorylates a series of substrates including Nbs1. Specific phosphorylation of Nbs1 on S287 and S343 plays a role in the activation of the intra-S-phase checkpoint (Lim et al., 2000) . Yazdi et al. (2002) showed that ATMdependent phosphorylation of Nbs1 was required for phosphorylation of SMC1, implying that Nbs1, presumably as part of the MRN complex, was an adaptor in an ATM/Nbs1/SMC1 pathway controlling the S-phase checkpoint. An adaptor role for phosphorylated Nbs1 has also been demonstrated in DNA-damage-induced suppression of Tousled-like kinase activity (Krause et al., 2003) . There is also some evidence that a second member of the MRN complex, Mre11, is phosphorylated in response to DNA damage (Dong et al., 1999; Yuan et al., 2002; Costanzo et al., 2004) . More recently, the use of large-scale and systematic proteomic analysis has identified a site on Rad50 that is phosphorylated in response to DNA damage (Linding et al., 2007; Matsuoka et al., 2007) . However, at this stage there is no evidence that these phosphorylations are functionally significant.
While the model outlined in Figure 2 describes well the series of events that apply in response to DNA damage in human cells, it is at variance with at least some data in mouse models. Pellegrini et al. (2006) demonstrated normal radiation-induced phosphorylation of Chk1, Chk2, p53 and SMC1 in a bacterial artificial chromosome-reconstituted Atm S1987A mutant mouse (Atm TgS1987A Atm
À/À
). Furthermore, enhanced retention of Atm-S1987A was observed at laser damage-induced sites, suggesting that the phosphositemutant could localize normally to DNA breaks. Cells from these mice had normal intra-S-phase and G 2 /M checkpoints and they were not hypersensitive to radiation. They further showed that while cell-cycle checkpoints and radiation survival were dependent upon the N-terminal FHA domain of Nbs1, neither the phosphorylated residues on Nbs1 nor its conserved C-terminus were important for these processes (Difilippantonio et al., 2007) . These data are interpreted to mean that Atm phosphorylation on S1987 is not the signal that leads to Atm monomerization and activation and that this autophosphorylation and downstream transphosphorylation is a consequence rather than a cause of Atm activation. One explanation for this is that the ATM activation in the mouse may be quite different from that in the human. This seems unlikely since the three autophosphorylation sites described for human cells are all conserved in the mouse. While efforts were made in the bacterial artificial chromosome approach to select founder lines expressing Atm-S1987A at levels similar to endogenous levels there was some evidence of overexpression (Pellegrini et al., 2006) . This might create a situation where an increased pool size of Atm in the vicinity of the break led to Atm activation without the need for autophosphorylation. Activation can occur in vitro by adding ATP or DNA ends to ATM without a requirement for pS1981 (Kozlov et al., 2003; Lee and Paull, 2005) . Indeed, there are other examples of ATM activation without evidence of phosphorylation on S1981 (Hamer et al., 2004; Powers et al., 2004) . In addition, it is evident that human ATM S1981A can be activated in vitro (Bakkenist and Kastan, 2003) . Under these conditions, Atm S1987A could be activated to phosphorylate downstream substrates giving rise to normal radiosensitivity response and normal cell-cycle checkpoint control in the Atm À/À background (Pellegrini et al., 2006) . With respect to the requirement for the C-terminus of Nbs1 for Atm activation, differences are observed in two mouse models. Pellegrini et al. (2006) reported a lack of requirement for the C-terminus (22 amino-acid deletion) of Nbs1 for Atm activation and signalling, cell cycle control and radiation survival. In a second mouse model with a closely related deletion (24 amino acids), Nbs1 DC/ DC Atm activation appeared to be normal but downstream signalling through SMC1 was defective (Stracker et al., 2007) . In addition, cells from these mice exhibited a defective intra-S-phase checkpoint, but had normal radiation sensitivity and chromosomal stability. Radiation-induced apoptosis was defective in both mouse models supporting a requirement for the C-terminus of Nbs1 in this process. The differences between the two mouse models might be explained by the different methods of generation of these models.
Much has been achieved in recent years in understanding how it is that ATM is activated. In human cells, it is evident that phosphorylation, dephosphorylation and acetylation play important roles in ATM activation. Amongst these changes, autophosphorylation on at least three sites is an inherent part of the activation mechanism. This does not appear to be important for murine Atm activation. However, in both cases the MRN complex acts as a sensor of the break for the recruitment and activation of Atm. No doubt the differences between the mouse and human will be shortly resolved and a greater knowledge of the series of events involved in ATM activation and its dependence on the MRN complex delineated in the not too distant future.
